CN106943356B - 一种泛昔洛韦缓释颗粒剂及其制备方法 - Google Patents
一种泛昔洛韦缓释颗粒剂及其制备方法 Download PDFInfo
- Publication number
- CN106943356B CN106943356B CN201710326337.5A CN201710326337A CN106943356B CN 106943356 B CN106943356 B CN 106943356B CN 201710326337 A CN201710326337 A CN 201710326337A CN 106943356 B CN106943356 B CN 106943356B
- Authority
- CN
- China
- Prior art keywords
- famciclovir
- sustained
- adhesive
- release granule
- hydroxypropyl methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
单个最大杂质 | 总杂质 | |
0天 | 0.05 | 0.32 |
10天 | 基本不变 | 基本不变 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710326337.5A CN106943356B (zh) | 2017-05-10 | 2017-05-10 | 一种泛昔洛韦缓释颗粒剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710326337.5A CN106943356B (zh) | 2017-05-10 | 2017-05-10 | 一种泛昔洛韦缓释颗粒剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106943356A CN106943356A (zh) | 2017-07-14 |
CN106943356B true CN106943356B (zh) | 2019-11-08 |
Family
ID=59479233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710326337.5A Active CN106943356B (zh) | 2017-05-10 | 2017-05-10 | 一种泛昔洛韦缓释颗粒剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106943356B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112168829B (zh) * | 2020-09-24 | 2022-02-15 | 华南理工大学 | 抗病毒药物在制备治疗骨髓增生异常综合征药物中的应用及制得的骨髓增生异常综合征药物 |
CN112057430A (zh) * | 2020-10-17 | 2020-12-11 | 迪沙药业集团有限公司 | 一种泛昔洛韦药物组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101212957A (zh) * | 2005-06-29 | 2008-07-02 | 万能药生物有限公司 | 药物缓释组合物及其制备方法 |
CN101269025A (zh) * | 2008-05-16 | 2008-09-24 | 北京正大绿洲医药科技有限公司 | 泛昔洛韦缓释滴丸及其制备方法 |
CN101502521A (zh) * | 2008-09-04 | 2009-08-12 | 山东淄博新达制药有限公司 | 阿昔洛韦缓释制剂组合物及其制备方法 |
CN101904825A (zh) * | 2010-07-29 | 2010-12-08 | 江苏晨牌药业有限公司 | 泛昔洛韦分散片及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2725623A1 (fr) * | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
-
2017
- 2017-05-10 CN CN201710326337.5A patent/CN106943356B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101212957A (zh) * | 2005-06-29 | 2008-07-02 | 万能药生物有限公司 | 药物缓释组合物及其制备方法 |
CN101269025A (zh) * | 2008-05-16 | 2008-09-24 | 北京正大绿洲医药科技有限公司 | 泛昔洛韦缓释滴丸及其制备方法 |
CN101502521A (zh) * | 2008-09-04 | 2009-08-12 | 山东淄博新达制药有限公司 | 阿昔洛韦缓释制剂组合物及其制备方法 |
CN101904825A (zh) * | 2010-07-29 | 2010-12-08 | 江苏晨牌药业有限公司 | 泛昔洛韦分散片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106943356A (zh) | 2017-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579367B (zh) | 托吡酯缓释药物组合物、其制备方法及用途 | |
CN102988296A (zh) | 塞来昔布固体分散体及其制备方法 | |
CN104447904B (zh) | 一种口服生物利用度高的稳定天麻素晶体及其制备方法、制剂与应用 | |
CN104523791B (zh) | 一种鲜人参活性提取物口崩片及其制备方法 | |
JP2016539955A (ja) | 薬物組成物、及びその製造方法、並びに使用 | |
CN106943356B (zh) | 一种泛昔洛韦缓释颗粒剂及其制备方法 | |
CN105343020A (zh) | 一种托匹司他片剂及其制备方法 | |
JP2016539173A (ja) | 広金銭草総フラボノイド含有経口固形製剤、及びその使用 | |
CN104458924B (zh) | 一种含有亲水凝胶骨架材料的制剂中有关物质的检测方法 | |
CN102276516A (zh) | 一种苯磺酸左旋氨氯地平晶体、其制备方法及含有该晶体的全新药物组合物 | |
CN103724374A (zh) | 一种苯磷硫胺化合物及制备方法及其含有该化合物的药物组合物 | |
CN105001223B (zh) | 一种恩替卡韦晶体化合物及其胶囊制剂 | |
CN104127510B (zh) | 小儿热速清颗粒矫味组合物及其颗粒剂和制法 | |
CN107245054B (zh) | 一种无定形草乌甲素化合物及其制备方法 | |
CN102228505B (zh) | 一种养心安神的中药组合物及其制备方法和检测方法 | |
CN102503935B (zh) | 一种阿折地平晶型及其制备方法和药用组合物 | |
CN105055353B (zh) | 一种恩替卡韦片及其制备方法 | |
CN106668027A (zh) | 奥贝胆酸药物组合物及其制备方法 | |
CA2525037C (en) | Microcrystals of (e)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine | |
CN112137965A (zh) | 一种头孢克洛颗粒药物组合物 | |
CN103239411B (zh) | 一种头孢地尼及枸橼酸和枸橼酸钠干混悬剂组合物 | |
CN113440487A (zh) | 一种金雀花碱片及其制备方法 | |
CN103772378A (zh) | 一种美洛昔康化合物及其片剂 | |
CN106511313B (zh) | 西洛他唑缓释胶囊组合物及其制备方法 | |
CN111714444B (zh) | 一种醋酸乌利司他口服固体制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Fen Inventor after: Liu Honghua Inventor after: Tang Wei Inventor after: Deng Xiafei Inventor after: Fang Zhi Inventor after: Chen Shi Inventor after: Chen Shenggang Inventor before: Deng Xiafei Inventor before: Liu Yanhong Inventor before: Fang Zhi Inventor before: Tang Wei Inventor before: Liu Honghua |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |